---
title: "WYY: Major federal contract wins and improved margins set the stage for accelerated growth"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295852306.md"
description: "Q2 2026 saw major contract wins, including the $3.1B DHS CWMS 3.0 and NASA SEWP VI, driving a strong outlook for revenue and profitability growth. Revenue and margins improved year-over-year, with a robust pipeline and new SaaS and DaaS opportunities supporting future expansion.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-13T21:51:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295852306.md)
  - [en](https://longbridge.com/en/news/295852306.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295852306.md)
generator: "portal-rs"
---

# WYY: Major federal contract wins and improved margins set the stage for accelerated growth

Q2 2026 saw major contract wins, including the $3.1B DHS CWMS 3.0 and NASA SEWP VI, driving a strong outlook for revenue and profitability growth. Revenue and margins improved year-over-year, with a robust pipeline and new SaaS and DaaS opportunities supporting future expansion.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [WYY.US](https://longbridge.com/en/quote/WYY.US.md)

## Related News & Research

- [WidePoint Q2 revenue rises, adjusted EBITDA jumps](https://longbridge.com/en/news/295841120.md)
- [TCS: Record SaaS growth and profitability drive raised guidance and strong cash flow](https://longbridge.com/en/news/298647711.md)
- [SAIL: Q2'27 delivered 25% ARR growth, margin expansion, and raised FY'27 guidance on strong SaaS momentum](https://longbridge.com/en/news/298445428.md)
- [Tecsys Reports Financial Results for the First Quarter of Fiscal 2027](https://longbridge.com/en/news/298646387.md)
- [Henry Schein (HSIC) Could Be 9% Undervalued On New Diagnostics Distribution Wins](https://longbridge.com/en/news/298815174.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**